Table 5.
F1 of the top 6 combinations.
| SR report topic | TI+AB F1 (%) |
TI+AB+MH F1 (%) |
TI+AB+PT F1 (%) |
TI+AB+AU F1 (%) |
TI+AB+PT+AU F1 (%) |
TI+AB+MH+PT+AU F1 (%) |
||||
| ACE inhibitors | 0.4156 (1) | 0.4000 (2) | 0.4051 (1) | 0.3902 (2) | 0.3971 (4) | 0.3774 (3) | ||||
| ADHD | 0.4000 (3) | 0.4688 (5) | 0.5455 (4) | 0.4286 (6) | 0.5306 (3) | 0.5818 (4) | ||||
| Antihistamines | 0.3226 (5) | 0.3333 (10) | 0.2903 (15) | 0.3226 (5) | 0.2903 (15) | 0.2813 (15) | ||||
| Atypical antipsychotics |
0.4364 (16) | 0.4241 (15) | 0.4887 (15) | 0.4411 (17) | 0.4856 (15) | 0.4606 (15) | ||||
| Beta blockers | 0.2800 (3) | 0.3043 (2) | 0.3590 (2) | 0.2667 (3) | 0.3596 (2) | 0.3333 (3) | ||||
| Calcium channel blockers |
0.2335 (8) | 0.2620 (11) | 0.2804 (9) | 0.2323 (8) | 0.2816 (9) | 0.2995 (9) | ||||
| Estrogens | 0.6000 (30) | 0.6237 (29) | 0.6047 (25) | 0.5979 (31) | 0.6118 (24) | 0.6171 (26) | ||||
| NSAIDS | 0.6667 (16) | 0.6154 (16) | 0.6966 (12) | 0.6471 (16) | 0.6809 (13) | 0.6667 (15) | ||||
| Opioids | 0.3000 (0) | 0.3158 (<1) | 0.3000 (<1) | 0.3000 (<1) | 0.3000 (<1) | 0.3158 (<1) | ||||
| Oral hypoglycemics | 0.4497 (90) | 0.4541 (88) | 0.4553 (86) | 0.4489 (92) | 0.4561 (75) | 0.4635 (82) | ||||
| Proton pump inhibitors |
0.4384 (7) | 0.4737 (5) | 0.5172 (5) | 0.4552 (7) | 0.5455 (5) | 0.5079 (6) | ||||
| Skeletal muscle relaxants |
0.2222 (1) | 0.2353 (<1) | 0.2500 (<1) | 0.2222 (1) | 0.2500 (<1) | 0.2667 (<1) | ||||
| Statins | 0.2994 (2) | 0.3281 (1) | 0.3382 (1) | 0.2959 (2) | 0.3358 (2) | 0.3465 (1) | ||||
| Triptans | 0.3636 (3) | 0.3913 (3) | 0.3556 (3) | 0.3556 (3) | 0.3529 (4) | 0.3913 (3) | ||||
| Urinary incontinence | 0.5063 (12) | 0.5347 (19) | 0.5505 (21) | 0.5263 (11) | 0.5507 (9) | 0.5843 (15) | ||||
| Averagea | 0.3956 (13) | 0.4110 (14) | 0.4291 (14) | 0.3954 (14) | 0.4286 (12) | 0.4329 (13) | ||||
a<1% is considered as 1% for calculating the average percentage.